Vasectomy and the risk of prostate cancer: A meta-analysis of cohort studies

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 10, 2015, Pages 17977-17985

  Zhang, Xiao Long ^a   Yan, Jia Jun ^a   Pan, Shou Hua ^a   Pan, Jian Gang ^a   Ying, Xiang Rong ^a   Zhang, Guan Fu ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Meta analysis; Prostate cancer; Risk; Vasectomy

Indexed keywords

ARTICLE; CANCER RISK; CANCER STAGING; DISEASE ASSOCIATION; HUMAN; META ANALYSIS; PROSTATE CANCER; SENSITIVITY ANALYSIS; VASECTOMY;

EID: 84952774173     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. [1] Baade PD, Youlden DR, Krnjacki LJ. International epidemiology of prostate cancer: geographical distribution and secular trends. Mol Nutr Food Res 2009; 53: 171-184.
2. [2] Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
3. [3] Hsing AW, Chokkalingam AP. Prostate cancer epidemiology. Front Biosci 2006; 11: 1388-1413.
4. [4] Brawley OW. Prostate cancer epidemiology in the United States. World J Urol 2012; 30: 195-200.
5. [5] Haas GP, Sakr WA. Epidemiology of prostate cancer. CA Cancer J Clin 1997; 47: 273-287.
6. [6] Schwingl PJ, Guess HA. Safety and effectiveness of vasectomy. Fertil Steril 2000; 73: 923-936.
7. [7] Massey FJ Jr, Bernstein GS, O’Fallon WM, Schuman LM, Coulson AH, Crozier R, Mandel JS, Benjamin RB, Berendes HW, Chang PC, et al. Vasectomy and health. Results from a large cohort study. JAMA 1984; 252: 1023-1029.
8. [8] Farley TM, Meirik O, Mehta S, Waites GM. The safety of vasectomy: recent concerns. Bull World Health Organ 1993; 71: 413-419.
9. [9] McDonald SW. Is vasectomy harmful to health? Br J Gen Pract 1997; 47: 381-386.
10. [10] Nienhuis H, Goldacre M, Seagroatt V, Gill L, Vessey M. Incidence of disease after vasectomy: a record linkage retrospective cohort study. BMJ 1992; 304: 743-746.
11. [11] Cox B, Sneyd MJ, Paul C, Delahunt B, Skegg DC. Vasectomy and risk of prostate cancer. JAMA 2002; 287: 3110-3115.
12. [12] Kohler TS, Fazili AA, Brannigan RE. Putative health risks associated with vasectomy. Urol Clin North Am 2009; 36: 337-345.
13. [13] Holt SK, Salinas CA, Stanford JL. Vasectomy and the risk of prostate cancer. J Urol 2008; 180: 2565-2567; discussion 2567-2568.
14. [14] Dennis LK, Dawson DV, Resnick MI. Vasectomy and the risk of prostate cancer: A meta-analysis examining vasectomy status, age at vasectomy, and time since vasectomy. Prostate Cancer Prostatic Dis 2002; 5: 193-203.
15. [15] Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 2010; 8: 336-341.
16. [16] Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012.
17. [17] Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603-605.
18. [18] Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
19. [19] DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
20. [20] Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992; 135: 1301-1309.
21. [21] Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 2012; 175: 66-73.
22. [22] Higgins JP, Thompson SG. Controlling the risk of spurious findings from meta-regression. Stat Med 2004; 23: 1663-1682.
23. [23] Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
24. [24] Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
25. [25] Sidney S, Quesenberry CP Jr, Sadler MC, Guess HA, Lydick EG, Cattolica EV. Vasectomy and the risk of prostate cancer in a cohort of multiphasic health-checkup examinees: Second report. Cancer Causes Control 1991; 2: 113-116.
26. [26] Giovannucci E, Ascherio A, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. A prospective cohort study of vasectomy and prostate cancer in US men. JAMA 1993; 269: 873-877.
27. [27] Giovannucci E, Tosteson TD, Speizer FE, Ascherio A, Vessey MP, Colditz GA. A retrospective cohort study of vasectomy and prostate cancer in US men. JAMA 1993; 269: 878-882.
28. [28] Moller H, Mellemgaard A, Lindvig K, Olsen JH. Obesity and cancer risk: A Danish record-linkage study. Eur J Cancer 1994; 30A: 344-350.
29. [29] Lynge E. Prostate cancer is not increased in men with vasectomy in denmark. J Urol 2002; 168: 488-490.
30. [30] Rohrmann S, Paltoo DN, Platz EA, Hoffman SC, Comstock GW, Helzlsouer KJ. Association of vasectomy and prostate cancer among men in a Maryland cohort. Cancer Causes Control 2005; 16: 1189-1194.
31. [31] Nie Y, Liu CR, Guo XK. Clinical study of long term effects of vasectomy on the incidence rate of prostate cancer. Journal of Clinical Urology 2008; 23: 424-427.
32. [32] Romero FR, Romero AW, Almeida RM, Oliveira FC Jr, Tambara Filho R. The significance of biological, environmental, and social risk factors for prostate cancer in a cohort study in Brazil. Int Braz J Urol 2012; 38: 769-778.
33. [33] Stanford JL, Wicklund KG, McKnight B, Daling JR, Brawer MK. Vasectomy and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 1999; 8: 881-886.
34. [34] Junghans C, Jones M. Consent bias in research: how to avoid it. Heart 2007; 93: 1024-1025.
35. [35] Kho ME, Duffett M, Willison DJ, Cook DJ, Brouwers MC. Written informed consent and selection bias in observational studies using medical records: systematic review. BMJ 2009; 338: b866.
36. [36] Al-Shahi R, Vousden C, Warlow C; Scottish Intracranial Vascular Malformation Study (SIVMS) Steering Committee. Bias from requiring explicit consent from all participants in observational research: prospective, population based study. BMJ 2005; 331: 942.
37. [37] Sarma AV, McLaughlin JC, Wallner LP, Dunn RL, Cooney KA, Schottenfeld D, Montie JE, Wei JT. Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men. J Urol 2006; 176: 1108-1113.
38. [38] Sutcliffe S. Sexually transmitted infections and risk of prostate cancer: review of historical and emerging hypotheses. Future Oncol 2010; 6: 1289-1311.
39. [39] Toh S, Gagne JJ, Rassen JA, Fireman BH, Kulldorff M, Brown JS. Confounding adjustment in comparative effectiveness research conducted within distributed research networks. Med Care 2013; 51: S4-10.
40. [40] Shariff-Marco S, Klassen AC, Bowie JV. Racial/ethnic differences in self-reported racism and its association with cancer-related health behaviors. Am J Public Health 2010; 100: 364-374.